nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—Telangiectasia—Methotrexate—muscle cancer	0.0344	0.0406	CcSEcCtD
Methysergide—Gravitational oedema—Doxorubicin—muscle cancer	0.0287	0.034	CcSEcCtD
Methysergide—Leg edema—Doxorubicin—muscle cancer	0.026	0.0308	CcSEcCtD
Methysergide—Urine output increased—Vincristine—muscle cancer	0.0151	0.0178	CcSEcCtD
Methysergide—HTR2A—hindlimb—muscle cancer	0.0138	0.0891	CbGeAlD
Methysergide—Polyuria—Vincristine—muscle cancer	0.0138	0.0163	CcSEcCtD
Methysergide—Pain in extremity—Vincristine—muscle cancer	0.0121	0.0143	CcSEcCtD
Methysergide—HTR2A—appendage—muscle cancer	0.0118	0.0765	CbGeAlD
Methysergide—Ataxia—Vincristine—muscle cancer	0.0114	0.0135	CcSEcCtD
Methysergide—Neutropenia—Dactinomycin—muscle cancer	0.011	0.013	CcSEcCtD
Methysergide—Pleural effusion—Methotrexate—muscle cancer	0.0106	0.0125	CcSEcCtD
Methysergide—HTR1F—head—muscle cancer	0.0101	0.0653	CbGeAlD
Methysergide—Neutropenia—Vincristine—muscle cancer	0.00979	0.0116	CcSEcCtD
Methysergide—Dysuria—Vincristine—muscle cancer	0.00979	0.0116	CcSEcCtD
Methysergide—Weight decreased—Vincristine—muscle cancer	0.00947	0.0112	CcSEcCtD
Methysergide—Pleural effusion—Doxorubicin—muscle cancer	0.00915	0.0108	CcSEcCtD
Methysergide—Hyperaesthesia—Doxorubicin—muscle cancer	0.00893	0.0106	CcSEcCtD
Methysergide—Oliguria—Methotrexate—muscle cancer	0.00878	0.0104	CcSEcCtD
Methysergide—HTR1E—head—muscle cancer	0.00875	0.0565	CbGeAlD
Methysergide—Flushing—Dactinomycin—muscle cancer	0.0087	0.0103	CcSEcCtD
Methysergide—Alopecia—Dactinomycin—muscle cancer	0.00829	0.0098	CcSEcCtD
Methysergide—Neutropenia—Etoposide—muscle cancer	0.00793	0.00938	CcSEcCtD
Methysergide—Oliguria—Doxorubicin—muscle cancer	0.00761	0.009	CcSEcCtD
Methysergide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00757	0.00896	CcSEcCtD
Methysergide—Alopecia—Vincristine—muscle cancer	0.0074	0.00876	CcSEcCtD
Methysergide—Malaise—Dactinomycin—muscle cancer	0.00736	0.00871	CcSEcCtD
Methysergide—Urine output increased—Methotrexate—muscle cancer	0.00732	0.00866	CcSEcCtD
Methysergide—Back pain—Vincristine—muscle cancer	0.00706	0.00835	CcSEcCtD
Methysergide—Myalgia—Dactinomycin—muscle cancer	0.00695	0.00822	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—muscle cancer	0.00687	0.00812	CcSEcCtD
Methysergide—HTR6—head—muscle cancer	0.00686	0.0444	CbGeAlD
Methysergide—Thrombophlebitis—Methotrexate—muscle cancer	0.00679	0.00803	CcSEcCtD
Methysergide—Polyuria—Methotrexate—muscle cancer	0.00669	0.00792	CcSEcCtD
Methysergide—Oedema—Dactinomycin—muscle cancer	0.00666	0.00788	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—muscle cancer	0.00662	0.00783	CcSEcCtD
Methysergide—Thrombocytopenia—Dactinomycin—muscle cancer	0.00652	0.00772	CcSEcCtD
Methysergide—Convulsion—Vincristine—muscle cancer	0.00632	0.00748	CcSEcCtD
Methysergide—Flushing—Etoposide—muscle cancer	0.0063	0.00745	CcSEcCtD
Methysergide—Myalgia—Vincristine—muscle cancer	0.00621	0.00735	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00607	0.00718	CcSEcCtD
Methysergide—Alopecia—Etoposide—muscle cancer	0.006	0.0071	CcSEcCtD
Methysergide—Oedema—Vincristine—muscle cancer	0.00595	0.00704	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—muscle cancer	0.00588	0.00695	CcSEcCtD
Methysergide—Thrombocytopenia—Vincristine—muscle cancer	0.00583	0.0069	CcSEcCtD
Methysergide—SIGMAR1—smooth muscle tissue—muscle cancer	0.0058	0.0375	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—muscle cancer	0.00579	0.0374	CbGeAlD
Methysergide—Fatigue—Dactinomycin—muscle cancer	0.00574	0.0068	CcSEcCtD
Methysergide—Back pain—Etoposide—muscle cancer	0.00572	0.00676	CcSEcCtD
Methysergide—Pain—Dactinomycin—muscle cancer	0.0057	0.00674	CcSEcCtD
Methysergide—Ataxia—Methotrexate—muscle cancer	0.00553	0.00654	CcSEcCtD
Methysergide—Feeling abnormal—Dactinomycin—muscle cancer	0.00549	0.0065	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—muscle cancer	0.00548	0.00649	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00545	0.00645	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00542	0.00642	CcSEcCtD
Methysergide—Insomnia—Vincristine—muscle cancer	0.00538	0.00637	CcSEcCtD
Methysergide—Paraesthesia—Vincristine—muscle cancer	0.00535	0.00632	CcSEcCtD
Methysergide—Malaise—Etoposide—muscle cancer	0.00533	0.0063	CcSEcCtD
Methysergide—Abdominal pain—Dactinomycin—muscle cancer	0.00527	0.00623	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—muscle cancer	0.00527	0.00623	CcSEcCtD
Methysergide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00514	0.00608	CcSEcCtD
Methysergide—Fatigue—Vincristine—muscle cancer	0.00513	0.00607	CcSEcCtD
Methysergide—Convulsion—Etoposide—muscle cancer	0.00512	0.00606	CcSEcCtD
Methysergide—Pain—Vincristine—muscle cancer	0.00509	0.00602	CcSEcCtD
Methysergide—Constipation—Vincristine—muscle cancer	0.00509	0.00602	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—muscle cancer	0.00509	0.00602	CcSEcCtD
Methysergide—Chest pain—Etoposide—muscle cancer	0.00503	0.00595	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—muscle cancer	0.00503	0.00595	CcSEcCtD
Methysergide—SIGMAR1—cardiac atrium—muscle cancer	0.005	0.0323	CbGeAlD
Methysergide—HTR1A—renal system—muscle cancer	0.00499	0.0322	CbGeAlD
Methysergide—Discomfort—Etoposide—muscle cancer	0.00497	0.00588	CcSEcCtD
Methysergide—HTR7—smooth muscle tissue—muscle cancer	0.00495	0.032	CbGeAlD
Methysergide—Gastrointestinal pain—Vincristine—muscle cancer	0.00487	0.00576	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—muscle cancer	0.00478	0.00566	CcSEcCtD
Methysergide—Asthenia—Dactinomycin—muscle cancer	0.00478	0.00566	CcSEcCtD
Methysergide—HTR7—renal system—muscle cancer	0.00477	0.0308	CbGeAlD
Methysergide—Neutropenia—Methotrexate—muscle cancer	0.00475	0.00562	CcSEcCtD
Methysergide—Dysuria—Methotrexate—muscle cancer	0.00475	0.00562	CcSEcCtD
Methysergide—Thrombocytopenia—Etoposide—muscle cancer	0.00472	0.00559	CcSEcCtD
Methysergide—Tachycardia—Etoposide—muscle cancer	0.00471	0.00557	CcSEcCtD
Methysergide—Body temperature increased—Vincristine—muscle cancer	0.00471	0.00557	CcSEcCtD
Methysergide—Abdominal pain—Vincristine—muscle cancer	0.00471	0.00557	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00465	0.0055	CcSEcCtD
Methysergide—Diarrhoea—Dactinomycin—muscle cancer	0.00456	0.00539	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—muscle cancer	0.00453	0.00536	CcSEcCtD
Methysergide—SIGMAR1—tendon—muscle cancer	0.00436	0.0282	CbGeAlD
Methysergide—Eosinophilia—Doxorubicin—muscle cancer	0.00435	0.00515	CcSEcCtD
Methysergide—HTR2B—tendon—muscle cancer	0.00435	0.0281	CbGeAlD
Methysergide—Paraesthesia—Etoposide—muscle cancer	0.00433	0.00512	CcSEcCtD
Methysergide—Dyspnoea—Etoposide—muscle cancer	0.0043	0.00509	CcSEcCtD
Methysergide—Somnolence—Etoposide—muscle cancer	0.00429	0.00507	CcSEcCtD
Methysergide—Asthenia—Vincristine—muscle cancer	0.00427	0.00505	CcSEcCtD
Methysergide—Vomiting—Dactinomycin—muscle cancer	0.00424	0.00501	CcSEcCtD
Methysergide—SIGMAR1—bone marrow—muscle cancer	0.00422	0.0273	CbGeAlD
Methysergide—Rash—Dactinomycin—muscle cancer	0.0042	0.00497	CcSEcCtD
Methysergide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00416	0.00493	CcSEcCtD
Methysergide—Fatigue—Etoposide—muscle cancer	0.00416	0.00492	CcSEcCtD
Methysergide—HTR1B—head—muscle cancer	0.00414	0.0267	CbGeAlD
Methysergide—Constipation—Etoposide—muscle cancer	0.00412	0.00488	CcSEcCtD
Methysergide—Pain—Etoposide—muscle cancer	0.00412	0.00488	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—muscle cancer	0.00411	0.00487	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—muscle cancer	0.00411	0.00487	CcSEcCtD
Methysergide—Diarrhoea—Vincristine—muscle cancer	0.00407	0.00482	CcSEcCtD
Methysergide—SIGMAR1—vagina—muscle cancer	0.00404	0.0261	CbGeAlD
Methysergide—HTR2B—vagina—muscle cancer	0.00403	0.0261	CbGeAlD
Methysergide—HTR1D—head—muscle cancer	0.00401	0.0259	CbGeAlD
Methysergide—Weight increased—Doxorubicin—muscle cancer	0.004	0.00474	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—muscle cancer	0.00398	0.00471	CcSEcCtD
Methysergide—Feeling abnormal—Etoposide—muscle cancer	0.00397	0.0047	CcSEcCtD
Methysergide—HTR2C—head—muscle cancer	0.00397	0.0256	CbGeAlD
Methysergide—Nausea—Dactinomycin—muscle cancer	0.00396	0.00468	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—muscle cancer	0.00394	0.00467	CcSEcCtD
Methysergide—Dizziness—Vincristine—muscle cancer	0.00394	0.00466	CcSEcCtD
Methysergide—HTR2A—embryo—muscle cancer	0.00393	0.0254	CbGeAlD
Methysergide—Drowsiness—Doxorubicin—muscle cancer	0.00392	0.00464	CcSEcCtD
Methysergide—Abdominal pain—Etoposide—muscle cancer	0.00381	0.00451	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—muscle cancer	0.00381	0.00451	CcSEcCtD
Methysergide—Vomiting—Vincristine—muscle cancer	0.00378	0.00448	CcSEcCtD
Methysergide—Rash—Vincristine—muscle cancer	0.00375	0.00444	CcSEcCtD
Methysergide—Dermatitis—Vincristine—muscle cancer	0.00375	0.00444	CcSEcCtD
Methysergide—HTR2B—head—muscle cancer	0.00373	0.0241	CbGeAlD
Methysergide—HTR7—tendon—muscle cancer	0.00372	0.0241	CbGeAlD
Methysergide—SIGMAR1—testis—muscle cancer	0.00361	0.0233	CbGeAlD
Methysergide—Alopecia—Methotrexate—muscle cancer	0.00359	0.00425	CcSEcCtD
Methysergide—Nausea—Vincristine—muscle cancer	0.00354	0.00418	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—muscle cancer	0.00347	0.0041	CcSEcCtD
Methysergide—Asthenia—Etoposide—muscle cancer	0.00346	0.00409	CcSEcCtD
Methysergide—Back pain—Methotrexate—muscle cancer	0.00342	0.00405	CcSEcCtD
Methysergide—HTR1A—head—muscle cancer	0.00334	0.0216	CbGeAlD
Methysergide—Diarrhoea—Etoposide—muscle cancer	0.0033	0.0039	CcSEcCtD
Methysergide—Ill-defined disorder—Methotrexate—muscle cancer	0.00328	0.00388	CcSEcCtD
Methysergide—Flushing—Doxorubicin—muscle cancer	0.00327	0.00387	CcSEcCtD
Methysergide—Malaise—Methotrexate—muscle cancer	0.00319	0.00378	CcSEcCtD
Methysergide—HTR7—head—muscle cancer	0.00319	0.0206	CbGeAlD
Methysergide—Dizziness—Etoposide—muscle cancer	0.00319	0.00377	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—muscle cancer	0.00311	0.00368	CcSEcCtD
Methysergide—HTR2A—smooth muscle tissue—muscle cancer	0.00309	0.02	CbGeAlD
Methysergide—HTR7—testis—muscle cancer	0.00308	0.0199	CbGeAlD
Methysergide—Convulsion—Methotrexate—muscle cancer	0.00307	0.00363	CcSEcCtD
Methysergide—Vomiting—Etoposide—muscle cancer	0.00307	0.00363	CcSEcCtD
Methysergide—Rash—Etoposide—muscle cancer	0.00304	0.0036	CcSEcCtD
Methysergide—Dermatitis—Etoposide—muscle cancer	0.00304	0.00359	CcSEcCtD
Methysergide—Chest pain—Methotrexate—muscle cancer	0.00301	0.00356	CcSEcCtD
Methysergide—Myalgia—Methotrexate—muscle cancer	0.00301	0.00356	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—muscle cancer	0.00301	0.00356	CcSEcCtD
Methysergide—Discomfort—Methotrexate—muscle cancer	0.00298	0.00352	CcSEcCtD
Methysergide—HTR2A—renal system—muscle cancer	0.00297	0.0192	CbGeAlD
Methysergide—Back pain—Doxorubicin—muscle cancer	0.00296	0.00351	CcSEcCtD
Methysergide—Nausea—Etoposide—muscle cancer	0.00286	0.00339	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00284	0.00336	CcSEcCtD
Methysergide—Thrombocytopenia—Methotrexate—muscle cancer	0.00283	0.00335	CcSEcCtD
Methysergide—Malaise—Doxorubicin—muscle cancer	0.00276	0.00327	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—muscle cancer	0.00266	0.00314	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00263	0.00311	CcSEcCtD
Methysergide—Insomnia—Methotrexate—muscle cancer	0.00261	0.00309	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—muscle cancer	0.00261	0.00309	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—muscle cancer	0.00261	0.00309	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—muscle cancer	0.00261	0.00309	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—muscle cancer	0.00259	0.00307	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—muscle cancer	0.00258	0.00305	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—muscle cancer	0.00258	0.00305	CcSEcCtD
Methysergide—Somnolence—Methotrexate—muscle cancer	0.00257	0.00304	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—muscle cancer	0.00254	0.00301	CcSEcCtD
Methysergide—Oedema—Doxorubicin—muscle cancer	0.0025	0.00296	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00249	0.00295	CcSEcCtD
Methysergide—Fatigue—Methotrexate—muscle cancer	0.00249	0.00295	CcSEcCtD
Methysergide—Pain—Methotrexate—muscle cancer	0.00247	0.00292	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—muscle cancer	0.00245	0.0029	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—muscle cancer	0.00244	0.00289	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—muscle cancer	0.00238	0.00282	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00236	0.00279	CcSEcCtD
Methysergide—HTR2A—tendon—muscle cancer	0.00232	0.015	CbGeAlD
Methysergide—Abdominal pain—Methotrexate—muscle cancer	0.00228	0.0027	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—muscle cancer	0.00228	0.0027	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00228	0.0027	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—muscle cancer	0.00226	0.00268	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—muscle cancer	0.00225	0.00266	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—muscle cancer	0.00223	0.00264	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—muscle cancer	0.00222	0.00263	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—muscle cancer	0.0022	0.0026	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00216	0.00255	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—muscle cancer	0.00216	0.00255	CcSEcCtD
Methysergide—HTR2A—vagina—muscle cancer	0.00215	0.0139	CbGeAlD
Methysergide—Constipation—Doxorubicin—muscle cancer	0.00214	0.00253	CcSEcCtD
Methysergide—Pain—Doxorubicin—muscle cancer	0.00214	0.00253	CcSEcCtD
Methysergide—Asthenia—Methotrexate—muscle cancer	0.00207	0.00245	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—muscle cancer	0.00206	0.00244	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00205	0.00242	CcSEcCtD
Methysergide—HTR2A—head—muscle cancer	0.00199	0.0129	CbGeAlD
Methysergide—Body temperature increased—Doxorubicin—muscle cancer	0.00198	0.00234	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—muscle cancer	0.00198	0.00234	CcSEcCtD
Methysergide—Diarrhoea—Methotrexate—muscle cancer	0.00198	0.00234	CcSEcCtD
Methysergide—HTR2A—testis—muscle cancer	0.00192	0.0124	CbGeAlD
Methysergide—Dizziness—Methotrexate—muscle cancer	0.00191	0.00226	CcSEcCtD
Methysergide—Vomiting—Methotrexate—muscle cancer	0.00184	0.00217	CcSEcCtD
Methysergide—Rash—Methotrexate—muscle cancer	0.00182	0.00215	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—muscle cancer	0.00182	0.00215	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—muscle cancer	0.00179	0.00212	CcSEcCtD
Methysergide—Nausea—Methotrexate—muscle cancer	0.00172	0.00203	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—muscle cancer	0.00171	0.00202	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—muscle cancer	0.00165	0.00196	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—muscle cancer	0.00159	0.00188	CcSEcCtD
Methysergide—Rash—Doxorubicin—muscle cancer	0.00158	0.00187	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—muscle cancer	0.00158	0.00186	CcSEcCtD
Methysergide—Nausea—Doxorubicin—muscle cancer	0.00149	0.00176	CcSEcCtD
